Clinical Trial Update: Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

This entry documents an ongoing Phase 3 clinical trial evaluating somatostatin receptor expression using PET imaging with 68Ga-DOTATOC in patients with metastat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 68Ga-DOTATOC (DOTATOC)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Breast Cancer Metastatic | Phase 3 | Status: RECRUITING